An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL Rabbits
- 23 October 1998
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 282 (5389) , 751-754
- https://doi.org/10.1126/science.282.5389.751
Abstract
Patients with abetalipoproteinemia, a disease caused by defects in the microsomal triglyceride transfer protein (MTP), do not produce apolipoprotein B–containing lipoproteins. It was hypothesized that small molecule inhibitors of MTP would prevent the assembly and secretion of these atherogenic lipoproteins. To test this hypothesis, two compounds identified in a high-throughput screen for MTP inhibitors were used to direct the synthesis of a highly potent MTP inhibitor. This molecule (compound 9) inhibited the production of lipoprotein particles in rodent models and normalized plasma lipoprotein levels in Watanabe-heritable hyperlipidemic (WHHL) rabbits, which are a model for human homozygous familial hypercholesterolemia. These results suggest that compound 9, or derivatives thereof, has potential applications for the therapeutic lowering of atherogenic lipoprotein levels in humans.Keywords
This publication has 11 references indexed in Scilit:
- Automated Synthesis and Purification of Amides: Exploitation of Automated Solid Phase Extraction in Organic SynthesisSynthesis, 1997
- An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells.Proceedings of the National Academy of Sciences, 1996
- A 30-Amino Acid Truncation of the Microsomal Triglyceride Transfer Protein Large Subunit Disrupts Its Interaction with Protein Disulfide-isomerase and Causes AbetalipoproteinemiaPublished by Elsevier ,1995
- Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer proteinHuman Molecular Genetics, 1993
- Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemiaNature, 1993
- Familial hypobetalipoproteinemia.Journal of Lipid Research, 1993
- Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissuesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Biochemical Analysis of Hepatic Lipid in Alcoholic and Diabetic and Control SubjectsClinical Science, 1983
- Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia.Proceedings of the National Academy of Sciences, 1981
- The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339Biochemical Journal, 1976